Literature DB >> 1805610

Effect of repeated occupational exposure to lead, cessation of exposure, and chelation on levels of lead in bone.

H Hu1, L Pepper, R Goldman.   

Abstract

A sensitive K-X-ray fluorescence (K-XRF) instrument was used to measure lead levels in the tibia and patella on a series of twelve subjects who had relatively well-documented histories of lead exposure and blood lead levels. For some subjects, K-XRF measurements were taken at multiple points in time, and before and after chelation with EDTA (ethylenediamine tetraacetic acid). Results confirm that K-XRF measured bone lead levels correspond to cumulative blood lead indices and not to current blood lead levels. Moreover, the data suggest that bone lead levels; (1) correspond to urinary lead following the EDTA mobilization test unless previous chelation has occurred; (2) rise initially after lead exposure ceases and blood lead levels decrease, probably from redistribution from soft tissue, and then fall; and (3) do not decrease with a 3- to 5-day course of therapeutic EDTA chelation. K-XRF levels in the patella were noted to decrease more rapidly than levels in the tibia after cessation of lead exposure, a finding that probably reflects the greater turnover of lead in trabecular bone than in cortical bone.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1805610     DOI: 10.1002/ajim.4700200603

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  19 in total

1.  Lead poisoning among pregnant women in New York City: risk factors and screening practices.

Authors:  Susan Klitzman; Anu Sharma; Leze Nicaj; Ramona Vitkevich; Jessica Leighton
Journal:  J Urban Health       Date:  2002-06       Impact factor: 3.671

Review 2.  Cumulative exposure to inorganic lead and neurobehavioural test performance in adults: an epidemiological review.

Authors:  J M Balbus-Kornfeld; W Stewart; K I Bolla; B S Schwartz
Journal:  Occup Environ Med       Date:  1995-01       Impact factor: 4.402

3.  Lead levels in bone and hair of rats treated with lead acetate.

Authors:  E Hać; J Krechniak
Journal:  Biol Trace Elem Res       Date:  1996-06       Impact factor: 3.738

4.  The associations between lead exposure at multiple sensitive life periods and dental caries risks in permanent teeth.

Authors:  Yue Wu; Erica C Jansen; Karen E Peterson; Betsy Foxman; Jaclyn M Goodrich; Howard Hu; Maritsa Solano-González; Alejandra Cantoral; Martha M Téllez-Rojo; Esperanza Angeles Martinez-Mier
Journal:  Sci Total Environ       Date:  2018-11-14       Impact factor: 7.963

5.  Predictors of dimercaptosuccinic acid chelatable lead and tibial lead in former organolead manufacturing workers.

Authors:  B S Schwartz; W F Stewart; A C Todd; J M Links
Journal:  Occup Environ Med       Date:  1999-01       Impact factor: 4.402

6.  109Cd K x ray fluorescence measurements of tibial lead content in young adults exposed to lead in early childhood.

Authors:  F E McNeill; L Stokes; J A Brito; D R Chettle; W E Kaye
Journal:  Occup Environ Med       Date:  2000-07       Impact factor: 4.402

7.  Provocative chelation with DMSA and EDTA: evidence for differential access to lead storage sites.

Authors:  B K Lee; B S Schwartz; W Stewart; K D Ahn
Journal:  Occup Environ Med       Date:  1995-01       Impact factor: 4.402

8.  Bone lead levels are associated with measures of memory impairment in older adults.

Authors:  Edwin van Wijngaarden; James R Campbell; Deborah A Cory-Slechta
Journal:  Neurotoxicology       Date:  2009-05-27       Impact factor: 4.294

Review 9.  Male reproductive toxicity of lead in animals and humans. ASCLEPIOS Study Group.

Authors:  P Apostoli; P Kiss; S Porru; J P Bonde; M Vanhoorne
Journal:  Occup Environ Med       Date:  1998-06       Impact factor: 4.402

10.  Comparison of measures of lead exposure, dose, and chelatable lead burden after provocative chelation in organolead workers.

Authors:  B S Schwartz; M P McGrail; W Stewart; T Pluth
Journal:  Occup Environ Med       Date:  1994-10       Impact factor: 4.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.